Celltrion
068270.KS
#754
Rank
A$40.86 B
Marketcap
$197.30
Share price
0.72%
Change (1 day)
4.99%
Change (1 year)
Celltrion is a Korean pharmaceutical company headquartered in Incheon, South Korea. Celltrion Healthcare conducts worldwide marketing, sales, and distribution of biological medicines developed by Celltrion.

Celltrion (068270.KS) - Total assets

Total assets on the balance sheet as of June 2024 : A$22.15 Billion

According to Celltrion 's latest financial reports the company's total assets are A$22.15 Billion. A companyโ€™s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.

Celltrion - Total assets on balance sheet (from 2007 to 2024)

Total assets by year

Year Total assets Change
2022-12-31A$6.86 B4.39%
2021-12-31A$6.57 B9.46%
2020-12-31A$6.00 B26.05%
2019-12-31A$4.76 B7.02%
2018-12-31A$4.45 B12.55%
2017-12-31A$3.95 B19.25%
2016-12-31A$3.31 B7.6%
2015-12-31A$3.08 B19.05%
2014-12-31A$2.59 B23.15%
2013-12-31A$2.10 B30.97%
2012-12-31A$1.60 B35.69%
2011-12-31A$1.18 B17.3%
2010-12-31A$1.00 B86.62%
2009-12-31A$0.54 B-5.07%
2008-12-31A$0.56 B650.7%
2007-12-31A$75.88 M